3 mg of retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity GLP-3 RT – True Lab

(Its founder is an entrepreneur who had previously worked in wristwatch-focused ecommerce.) A buzzy New York Times profile touted its achievements, but also sparked conversation about issues related to how it was marketed, including a February Food and Drug Administration warning letter addressed to the company

Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B

Weekly dosing lowered animal stress and allowed long monitoring

Conclusions In summary, this study provides comprehensive mechanistic insights into how Retatrutide, a triple agonist of the GIP, GLP-1, and glucagon receptors, exerts potent anti-obesity and metabolic benefits through coordinated molecular and metabolic remodeling of adipose tissue